University Of Pittsburgh

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1787-02-28

Employees: 10K

Market Cap: -

Website: http://www.pitt.edu

Clinical Trials

Effect of Antacids on Gleevec® in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Imatimib Mesylate (Gleevec®)
Drug: Antacids (Mg-Al-based)

First Posted Date: 2007-03-12

Last Posted Date: 2016-06-22

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 12

Registration Number: NCT00446316

Locations: 🇺🇸
University of Pittsburgh Cancer Institute / Clinical and Translational Research Center (Hillman Cancer Center and Montefiore University Hospital locations), Pittsburgh, Pennsylvania, United States

Effect of a Proton Pump Inhibitor on Gleevec® in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Imatinib Mesylate
Drug: Omeprazole

First Posted Date: 2007-03-12

Last Posted Date: 2016-06-22

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 15

Registration Number: NCT00446004

Locations: 🇺🇸
University of Pittsburgh Cancer Institute / Clinical and Translational Research Center (Hillman Cancer Center and Montefiore University Hospital locations), Pittsburgh, Pennsylvania, United States

Treatment of Depressed Adolescents With Physical Illness

Not Applicable

Completed

Conditions: Inflammatory Bowel Disease
Depression

Interventions: Behavioral: Cognitive Behavioral Therapy
Behavioral: Standard of Community Care Treatment

First Posted Date: 2007-03-12

Last Posted Date: 2014-05-20

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 41

Registration Number: NCT00446238

Locations: 🇺🇸
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸
Children's Hospital Boston, Boston, Massachusetts, United States

Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study

Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Biological: control dendritic cells
Biological: Diabetes-suppressive dendritic cell vaccine

First Posted Date: 2007-03-09

Last Posted Date: 2016-02-15

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 10

Registration Number: NCT00445913

Locations: 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC

Completed

Conditions: Gram Negative Organism

First Posted Date: 2007-03-07

Last Posted Date: 2018-06-12

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 500

Registration Number: NCT00443885

Locations: 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
🇺🇸
UPMC, Pittsburgh, Pennsylvania, United States

Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers

Phase 2

Completed

Conditions: Venous Thrombosis
Pulmonary Embolism

First Posted Date: 2007-02-19

Last Posted Date: 2008-05-16

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 21

Registration Number: NCT00436787

Locations: 🇺🇸
Magee Women's Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸
Shadyside Medical Building, Pittsburgh, Pennsylvania, United States

Longitudinal Assessment of Bariatric Surgery

Completed

Conditions: Morbid Obesity

First Posted Date: 2007-02-12

Last Posted Date: 2010-12-24

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 5102

Registration Number: NCT00433810

Locations: 🇺🇸
Neuropsychiatric Research Institute, Fargo, North Dakota, United States
🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
🇺🇸
Sacramento Bariatric, Sacramento, California, United States

and more 7 locations

Bone Metabolism and Parathyroid Hormone-related Protein (PTHrP) Lactation Study

Completed

Conditions: Bone Diseases, Endocrine

First Posted Date: 2007-02-01

Last Posted Date: 2013-10-31

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 49

Registration Number: NCT00430417

Locations: 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States

A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen

Not Applicable

Completed

Conditions: Hemoglobinopathies
Sickle Cell Disease
Thalassemia

Interventions: Other: Busulfan; Fludarabine; cyclosporine A and MMF

First Posted Date: 2007-01-29

Last Posted Date: 2016-08-18

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 8

Registration Number: NCT00427661

Locations: 🇺🇸
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States

Effectiveness of Human Simulation Training for Medical Crisis Management Skills

Phase 1

Withdrawn

Conditions: Education

Interventions: Behavioral: Human Simulation Training

First Posted Date: 2007-01-22

Last Posted Date: 2014-12-04

Lead Sponsor: University of Pittsburgh

Registration Number: NCT00425295

Locations: 🇺🇸
University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy